A randomized phase II trial of two dosage levels of letrozole as third- line hormonal therapy for women with metastatic breast carcinoma

James N. Ingle, Patricia A. Johnson, Vera J. Suman, James B. Gerstner, James A. Mailliard, John K. Camoriano, Dean H. Gesme, Charles L. Loprinzi, Alan K. Hatfield, Lynn C. Hartmann

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II trial of two dosage levels of letrozole as third- line hormonal therapy for women with metastatic breast carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences